During the past decade, Yuaikai Tomishiro Central Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yuaikai Tomishiro Central Hospital" are "Crohn's Disease" (1 trials) and "VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery" (1 trials). Many other conditions were trialed in "Yuaikai Tomishiro Central Hospital" in a lesser frequency.

Most popular intervention types in "Yuaikai Tomishiro Central Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban 2.5 mg" (1 trials), "Apixaban placebo" (1 trials), "Guselkumab" (1 trials), "Guselkumab Dose 1" (1 trials) and "Guselkumab Dose 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yuaikai Tomishiro Central Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yuaikai Tomishiro Central Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yuaikai Tomishiro Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yuaikai Tomishiro Central Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".